Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 503

1.

Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.

Rochira V, Zirilli L, Madeo B, Aranda C, Caffagni G, Fabre B, Montangero VE, Roldan EJ, Maffei L, Carani C.

Bone. 2007 Jun;40(6):1662-8. Epub 2007 Feb 27.

PMID:
17400043
2.

Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men.

Khosla S, Melton LJ 3rd, Robb RA, Camp JJ, Atkinson EJ, Oberg AL, Rouleau PA, Riggs BL.

J Bone Miner Res. 2005 May;20(5):730-40. Epub 2004 Dec 20.

3.

Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.

Leder BZ, Finkelstein JS.

Osteoporos Int. 2005 Dec;16(12):1487-94. Epub 2005 Apr 23.

PMID:
15856361
4.
5.

Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.

Szulc P, Munoz F, Duboeuf F, Marchand F, Delmas PD.

Bone. 2006 Apr;38(4):595-602. Epub 2005 Oct 24.

PMID:
16249130
6.

Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model.

Vanderschueren D, Boonen S, Ederveen AG, de Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A, Bouillon R.

Bone. 2000 Nov;27(5):611-7.

PMID:
11062346
7.

Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity.

Taes Y, Lapauw B, Vandewalle S, Zmierczak H, Goemaere S, Vanderschueren D, Kaufman JM, T'Sjoen G.

Bone. 2009 Aug;45(2):392-7. doi: 10.1016/j.bone.2009.04.198. Epub 2009 Apr 17.

PMID:
19376280
8.

Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.

Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K.

Osteoporos Int. 2005 Jul;16(7):791-8. Epub 2004 Oct 16.

PMID:
15502960
9.

A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.

Lanfranco F, Zirilli L, Baldi M, Pignatti E, Corneli G, Ghigo E, Aimaretti G, Carani C, Rochira V.

Bone. 2008 Sep;43(3):628-35. doi: 10.1016/j.bone.2008.05.011. Epub 2008 May 23.

PMID:
18590994
10.

Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study.

Lorentzon M, Swanson C, Eriksson AL, Mellström D, Ohlsson C.

J Bone Miner Res. 2006 Feb;21(2):332-9. Epub 2005 Nov 11.

11.

Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase.

Peng Z, Li X, Mäkelä S, Väänänen HK, Poutanen M.

J Bone Miner Res. 2004 Aug;19(8):1320-8. Epub 2004 May 24.

12.

Body composition, volumetric and areal bone parameters in male-to-female transsexual persons.

Lapauw B, Taes Y, Simoens S, Van Caenegem E, Weyers S, Goemaere S, Toye K, Kaufman JM, T'Sjoen GG.

Bone. 2008 Dec;43(6):1016-21. doi: 10.1016/j.bone.2008.09.001. Epub 2008 Sep 16.

PMID:
18835591
13.

The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches.

Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P.

Clin Endocrinol (Oxf). 1995 Mar;42(3):279-87.

PMID:
7758233
14.

The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model.

Vandenput L, Swinnen JV, Van Herck E, Verstuyf A, Boonen S, Bouillon R, Vanderschueren D.

Calcif Tissue Int. 2002 Mar;70(3):170-5. Epub 2002 Jan 28.

PMID:
11907714
15.
16.

Altered bone mineral density in patients with complete androgen insensitivity syndrome.

Bertelloni S, Baroncelli GI, Federico G, Cappa M, Lala R, Saggese G.

Horm Res. 1998;50(6):309-14.

PMID:
9973670
17.

Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones.

van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J.

Clin Endocrinol (Oxf). 1998 Mar;48(3):347-54.

PMID:
9578826
18.

Bone metabolism in men: role of aromatase activity.

Nuti R, Martini G, Merlotti D, De Paola V, Valleggi F, Gennari L.

J Endocrinol Invest. 2007;30(6 Suppl):18-23. Review.

PMID:
17721069
19.

Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency.

Herrmann BL, Janssen OE, Hahn S, Broecker-Preuss M, Mann K.

Horm Metab Res. 2005 Mar;37(3):178-83.

PMID:
15824973
20.

Androgen replacement in aging men.

Francis RM.

Calcif Tissue Int. 2001 Oct;69(4):235-8. Review.

PMID:
11730258

Supplemental Content

Support Center